AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2009
Jun 2, 2009
32814_dirs_2009-06-02_96603a37-acd3-4e01-ba81-4f78dfe7996e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2009-06-02
Reporting Person: BANSAL AJAY (EVP Corp Dev and CFO)
More from LEXICON PHARMACEUTICALS, INC.
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3